06.21.11
Atrium Innovations Inc., Quebec City, Quebec, Canada, has committed to a multi-year nutrition research program focused on metabolic syndrome. This global effort will be conducted in collaboration with a strategic partner, the Institute of Nutraceuticals and Functional Foods (INAF). The total current funding for related projects planned and in progress is more than $5 million, and includes partial support from governmental agencies.
Atrium’s research involves gaining a better understanding of metabolic syndrome and investigating the impact of nutrition on the prevention and treatment of silent inflammation associated with this condition. More specifically, research will emphasize the health benefits of small fruits, the anti-inflammatory mechanisms of specific fish oil fractions in the prevention of cardiovascular disease, probiotic, and systemic enzyme therapy in the management of inflammation and health promotion.
Atrium’s research involves gaining a better understanding of metabolic syndrome and investigating the impact of nutrition on the prevention and treatment of silent inflammation associated with this condition. More specifically, research will emphasize the health benefits of small fruits, the anti-inflammatory mechanisms of specific fish oil fractions in the prevention of cardiovascular disease, probiotic, and systemic enzyme therapy in the management of inflammation and health promotion.
